Patent ID: 7772227

Claim:
A tricyclic 1-[(indol-3-yl)carbonyl]piperazine derivative having the general Formula I wherein X is CH 2 , O or S; R represents 1-3 substituents independently selected from H, (C 1-4 )alkyl, (C 1-4 )alkyloxy and halogen; R 1 is (C 5-8 )cycloalkyl; R 2 is H or (C 1-4 )alkyl; R 3 , R 3 ′, R 4 , R 4 ′, R 5 , R 5 ′ and R 6 ′ are independently hydrogen or (C 1-4 )alkyl, optionally substituted with (C 1-4 alkyloxy, OH or halogen; R 6 is hydrogen or (C 1-4 alkyl, optionally substituted with (C 1-4 alkyloxy, OH or halogen; or R 6 forms together with R 7 a 4-7 membered saturated heterocyclic ring having only carbons as additional ring members; or R 7 is H, (C 1-4 )alkyl or (C 3-5 )cycloalkyl, the alkyl groups being optionally substituted with OH, halogen or (C 1-4 )alkyloxy; or a pharmaceutically acceptable salt thereof.